This finding agrees with the theory of Bauerle et al. [43] that global regulation of thyroid cancer cell growth is not achieved by NF-κB signaling alone and indicates that NF-κB (pathway) may not be the main target of DEX inhibiting the 3D growth of FTC-133 cells in μg. The gene discussed is NFKB1; the disease is thyroid cancer.